Publications list

Reijmen E; De Mey S; De Mey W; Gevaert T; De Ridder K; Locy H; Martens S; De Blay E; Bouwens L; Debie P; Breckpot K; De Grève J; De Ridder M; Goyvaerts C, 2021. Fractionated Radiation Severely Reduces the Number of CD8+ T Cells and Mature Antigen Presenting Cells Within Lung Tumors.  Int J Radiat Oncol Biol Phys 111(1):272-283

Engels B; Gevaert T; De Ridder M, 2021. Letter to the editor regarding the article "Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: Clinical implementation and initial experience" by Intven et al.  Radiother Oncol 158:244-245

Vinh-Hung V; Everaert H; Gorobets O; Van Parijs H; Verfaillie G; Vanhoeij M; Storme G; Fontaine C; Lamote J; Perrin J; Farid K; Nguyen NP; Verschraegen C; De Ridder M, 2021. Breast cancer preoperative 18FDG-PET, overall survival prognostic separation compared with the lymph node ratio.  Breast Cancer 28(4):956-968

Dupont C; De Schreye R; Cohen J; De Ridder M; Van den Block L; Deliens L; Leemans K, 2021. Pilot Study to Develop and Test Palliative Care Quality Indicators for Nursing Homes.  Int J Environ Res Public Health 18.

de Mey S; Dufait I; Jiang H; Corbet C; Wang H; Van De Gucht M; Kerkhove L; Law KL; Vandenplas H; Gevaert T; Feron O; De Ridder M, 2020. Dichloroacetate Radiosensitizes Hypoxic Breast Cancer Cells.  Int J Mol Sci 21.

Heymann S; Dipasquale G; Nguyen NP; San M; Gorobets O; Leduc N; Verellen D; Storme G; Van Parijs H; De Ridder M; Vinh-Hung V, 2020. Two-Level Factorial Pre-TomoBreast Pilot Study of Tomotherapy and Conventional Radiotherapy in Breast Cancer: Post Hoc Utility of a Mean Absolute Dose Deviation Penalty Score.  Technol Cancer Res Treat 19:1533033820947759

Rogiers A; Leys C; Lauwyck J; Schembri A; Awada G; Schwarze JK; De Cremer J; Theuns P; Maruff P; De Ridder M; Bernheim JL; Neyns B, 2020. Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab.  J Immunol Res 2020:2192480

Mulliez T; Barbé K; de Ridder M, 2020. Estimating lung cancer and cardiovascular mortality in female breast cancer patients receiving radiotherapy.  Radiother Oncol 152:111-116

Kleijnen JJE; van Asselen B; Van den Begin R; Intven M; Burbach JPM; Reerink O; Philippens MEP; de Ridder M; Lagendijk JJW; Raaymakers BW, 2019. MRI-based tumor inter-fraction motion statistics for rectal cancer boost radiotherapy.  Acta Oncol 58(2):232-236

Wang H; Jiang H; Van De Gucht M; De Ridder M, 2019. Hypoxic Radioresistance: Can ROS Be the Key to Overcome It?  Cancers (Basel) 11.

Van den Begin R; Engels B; Collen C; de Vin T; Defauw A; Dubaere E; Barbé K; De Ridder M, 2019. The METABANK score: A clinical tool to predict survival after stereotactic radiotherapy for oligometastatic disease.  Radiother Oncol 133:113-119

Wang H; Jiang H; Corbet C; de Mey S; Law K; Gevaert T; Feron O; De Ridder M, 2019. Piperlongumine increases sensitivity of colorectal cancer cells to radiation: Involvement of ROS production via dual inhibition of glutathione and thioredoxin systems.  Cancer Lett 450:42-52

Dufait I; Pardo J; Escors D; De Vlaeminck Y; Jiang H; Keyaerts M; De Ridder M; Breckpot K, 2019. Perforin and Granzyme B Expressed by Murine Myeloid-Derived Suppressor Cells: A Study on Their Role in Outgrowth of Cancer Cells.  Cancers (Basel) 11.

Maetens A; Deliens L; De Bleecker J; Caraceni A; De Ridder M; Beernaert K; Cohen J, 2019. Healthcare utilization at the end of life in people dying from amyotrophic lateral sclerosis: A retrospective cohort study using linked administrative data.  J Neurol Sci 406:116444

Locy H; de Mey S; de Mey W; De Ridder M; Thielemans K; Maenhout SK, 2018. Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend.  Front Immunol 9:2909

de Mey S; Jiang H; Corbet C; Wang H; Dufait I; Law K; Bastien E; Verovski V; Gevaert T; Feron O; De Ridder M, 2018. Antidiabetic Biguanides Radiosensitize Hypoxic Colorectal Cancer Cells Through a Decrease in Oxygen Consumption.  Front Pharmacol 9:1073

Jiang H; Wang H; De Ridder M, 2018. Targeting antioxidant enzymes as a radiosensitizing strategy.  Cancer Lett 438:154-164

de Mey S; Jiang H; Wang H; Engels B; Gevaert T; Dufait I; Feron O; Aerts J; Verovski V; De Ridder M, 2018. Potential of memory T cells in bridging preoperative chemoradiation and immunotherapy in rectal cancer.  Radiother Oncol 127(3):361-369

Van den Begin R; Kleijnen JP; Engels B; Philippens M; van Asselen B; Raaymakers B; Reerink O; De Ridder M; Intven M, 2018. Tumor volume regression during preoperative chemoradiotherapy for rectal cancer: a prospective observational study with weekly MRI.  Acta Oncol 57(6):723-727

Dhont J; Vandemeulebroucke J; Burghelea M; Poels K; Depuydt T; Van Den Begin R; Jaudet C; Collen C; Engels B; Reynders T; Boussaer M; Gevaert T; De Ridder M; Verellen D, 2018. The long- and short-term variability of breathing induced tumor motion in lung and liver over the course of a radiotherapy treatment.  Radiother Oncol 126(2):339-346

Gandia P; Jaudet C; Everaert H; Heemskerk J; Vanbinst AM; de Mey J; Duerinck J; Neyns B; de Ridder M; Chatelut E; Concordet D, 2017. Population Pharmacokinetic Approach Applied to Positron Emission Tomography: Computed Tomography for Tumor Tissue Identification in Patients with Glioma.  Clin Pharmacokinet 56(8):953-961

Wang H; Bouzakoura S; de Mey S; Jiang H; Law K; Dufait I; Corbet C; Verovski V; Gevaert T; Feron O; Van den Berge D; Storme G; De Ridder M, 2017. Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species.  Oncotarget 8(22):35728-35742

Burghelea M; Verellen D; Dhont J; Hung C; Gevaert T; Van den Begin R; Collen C; Poels K; Tournel K; Boussaer M; Jaudet C; Reynders T; Simon V; de Ridder M, 2017. Treating patients with Dynamic Wave Arc: First clinical experience.  Radiother Oncol 122(3):347-351

Storme G; Dhaese S; Corens D; De Ridder M, 2016. The cost of cancer care is not related to its outcomes.  Ecancermedicalscience 10:687

Isella C; Terrasi A; Bellomo SE; Petti C; Galatola G; Muratore A; Mellano A; Senetta R; Cassenti A; Sonetto C; Inghirami G; Trusolino L; Fekete Z; De Ridder M; Cassoni P; Storme G; Bertotti A; Medico E, 2016. Corrigendum: Stromal contribution to the colorectal cancer transcriptome.  Nat Genet 48(10):1296

Verbanck S; Hanon S; Schuermans D; Van Parijs H; Vinh-Hung V; Miedema G; Verellen D; Storme G; Fontaine C; Lamote J; De Ridder M; Vincken W, 2016. Mild Lung Restriction in Breast Cancer Patients After Hypofractionated and Conventional Radiation Therapy: A 3-Year Follow-Up.  Int J Radiat Oncol Biol Phys 95(3):937-945

Van den Begin R; Engels B; Boussaer M; Dhont J; Burghelea M; Depuydt T; Poels K; Collen C; Gevaert T; Verellen D; Storme G; de Mey J; De Ridder M, 2016. Motion management during SBRT for oligometastatic cancer: Results of a prospective phase II trial.  Radiother Oncol 119(3):519-24

Burghelea M; Verellen D; Poels K; Hung C; Nakamura M; Dhont J; Gevaert T; Van den Begin R; Collen C; Matsuo Y; Kishi T; Simon V; Hiraoka M; de Ridder M, 2016. Initial characterization, dosimetric benchmark and performance validation of Dynamic Wave Arc.  Radiat Oncol 11:63

Dufait I; Van Valckenborgh E; Menu E; Escors D; De Ridder M; Breckpot K, 2016. Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapy.  Oncotarget 7(27):42698-42715

Leonard W; Dufait I; Schwarze JK; Law K; Engels B; Jiang H; Van den Berge D; Gevaert T; Storme G; Verovski V; Breckpot K; De Ridder M, 2016. Myeloid-derived suppressor cells reveal radioprotective properties through arginase-induced l-arginine depletion.  Radiother Oncol 119(2):291-9

Gevaert T; Steenbeke F; Pellegri L; Engels B; Christian N; Hoornaert MT; Verellen D; Mitine C; De Ridder M, 2016. Evaluation of a dedicated brain metastases treatment planning optimization for radiosurgery: a new treatment paradigm?  Radiat Oncol 11:13

Steenbeke F; Gevaert T; Tournel K; Engels B; Verellen D; Storme G; De Ridder M, 2016. Quality Assurance of a 50-kV Radiotherapy Unit Using EBT3 GafChromic Film: A Feasibility Study.  Technol Cancer Res Treat 15(1):163-70

Mast M; Reynders T; Heijenbrok M; van Kempen-Harteveld L; Van Parijs H; Rozema H; Petoukhova A; Verellen D; De Ridder M; Struikmans H, 2016. Tangential IMRT versus TomoTherapy with and without breath-hold in left-sided whole breast irradiation.  Acta Oncol 55(2):240-3

Dufait I; Schwarze JK; Liechtenstein T; Leonard W; Jiang H; Escors D; De Ridder M; Breckpot K, 2015. Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer.  Oncotarget 6(14):12369-82

Sermeus A; Engels B; Urbain D; De Ridder M, 2015. Advances in radiotherapy delivery for rectal cancer: a European perspective.  Expert Rev Gastroenterol Hepatol 9(4):393-7

Isella C; Terrasi A; Bellomo SE; Petti C; Galatola G; Muratore A; Mellano A; Senetta R; Cassenti A; Sonetto C; Inghirami G; Trusolino L; Fekete Z; De Ridder M; Cassoni P; Storme G; Bertotti A; Medico E, 2015. Stromal contribution to the colorectal cancer transcriptome.  Nat Genet 47(4):312-9

Matsuo Y; Verellen D; Poels K; Mukumoto N; Depuydt T; Akimoto M; Nakamura M; Ueki N; Engels B; Collen C; Kokubo M; Hiraoka M; de Ridder M, 2015. A multi-centre analysis of treatment procedures and error components in dynamic tumour tracking radiotherapy.  Radiother Oncol 115(3):412-8

Burghelea M; Verellen D; Poels K; Gevaert T; Depuydt T; Tournel K; Hung C; Simon V; Hiraoka M; de Ridder M, 2015. Geometric Verification of Dynamic Wave Arc Delivery With the Vero System Using Orthogonal X-ray Fluoroscopic Imaging.  Int J Radiat Oncol Biol Phys 92(4):754-61

Poels K; Dhont J; Verellen D; Blanck O; Ernst F; Vandemeulebroucke J; Depuydt T; Storme G; De Ridder M, 2015. A comparison of two clinical correlation models used for real-time tumor tracking of semi-periodic motion: A focus on geometrical accuracy in lung and liver cancer patients.  Radiother Oncol 115(3):419-24

Kunos CA; Fabien JM; Shanahan JP; Collen C; Gevaert T; Poels K; Van den Begin R; Engels B; De Ridder M, 2015. Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy.  J Vis Exp.

Dhont J; Verellen D; Poels K; Tournel K; Burghelea M; Gevaert T; Collen C; Engels B; Van Den Begin R; Buls N; Van Gompel G; Van Cauteren T; Storme G; De Ridder M, 2015. Feasibility of markerless tumor tracking by sequential dual-energy fluoroscopy on a clinical tumor tracking system.  Radiother Oncol 117(3):487-90

Engels B; Soete G; Gevaert T; Storme G; Michielsen D; De Ridder M, 2014. Impact of planning target volume margins and rectal distention on biochemical failure in image-guided radiotherapy of prostate cancer.  Radiother Oncol 111(1):106-9

Sermeus A; Leonard W; Engels B; De Ridder M, 2014. Advances in radiotherapy and targeted therapies for rectal cancer.  World J Gastroenterol 20(1):1-5

Burghelea M; Verellen D; Gevaert T; Depuydt T; Poels K; Simon V; De Ridder M, 2014. Feasibility of using the Vero SBRT system for intracranial SRS.  J Appl Clin Med Phys 15(1):4437

Van Parijs H; Reynders T; Heuninckx K; Verellen D; Storme G; De Ridder M, 2014. Breast conserving treatment for breast cancer: dosimetric comparison of different non-invasive techniques for additional boost delivery.  Radiat Oncol 9:36

Engels B; Platteaux N; Van den Begin R; Gevaert T; Sermeus A; Storme G; Verellen D; De Ridder M, 2014. Preoperative intensity-modulated and image-guided radiotherapy with a simultaneous integrated boost in locally advanced rectal cancer: report on late toxicity and outcome.  Radiother Oncol 110(1):155-9

Depuydt T; Poels K; Verellen D; Engels B; Collen C; Buleteanu M; Van den Begin R; Boussaer M; Duchateau M; Gevaert T; Storme G; De Ridder M, 2014. Treating patients with real-time tumor tracking using the Vero gimbaled linac system: implementation and first review.  Radiother Oncol 112(3):343-51

Poels K; Verellen D; Van de Vondel I; El Mazghari R; Depuydt T; De Ridder M, 2014. Fiducial marker and marker-less soft-tissue detection using fast MV fluoroscopy on a new generation EPID: investigating the influence of pulsing artifacts and artifact suppression techniques.  Med Phys 41(10):101911

Van den Begin R; Engels B; Gevaert T; Duchateau M; Tournel K; Verellen D; Storme G; De Ridder M, 2014. Impact of inadequate respiratory motion management in SBRT for oligometastatic colorectal cancer.  Radiother Oncol 113(2):235-9

Poels K; Depuydt T; Verellen D; Gevaert T; Dhont J; Duchateau M; Burghelea M; Boussaer M; Steenbeke F; Collen C; Engels B; Storme G; De Ridder M, 2014. Improving the intra-fraction update efficiency of a correlation model used for internal motion estimation during real-time tumor tracking for SBRT patients: fast update or no update?  Radiother Oncol 112(3):352-9

Steenbeke F; Gevaert T; Engels B; Poels K; D'Haens J; Van Tussenbroek F; Verellen D; Storme G; De Ridder M, 2014. Analysis of the targeting uncertainty of a stereotactic frameless radiosurgery technique for arteriovenous malformation.  Radiother Oncol 113(3):371-3

Van Parijs H; Reynders T; Heuninckx K; Verellen D; Storme G; De Ridder M, 2014. Breast conserving treatment for breast cancer: dosimetric comparison of sequential versus simultaneous integrated photon boost.  Biomed Res Int 2014:827475

Depuydt T; Poels K; Verellen D; Engels B; Collen C; Haverbeke C; Gevaert T; Buls N; Van Gompel G; Reynders T; Duchateau M; Tournel K; Boussaer M; Steenbeke F; Vandenbroucke F; De Ridder M, 2013. Initial assessment of tumor tracking with a gimbaled linac system in clinical circumstances: a patient simulation study.  Radiother Oncol 106(2):236-40

Jiang H; Verovski VN; Leonard W; Law KL; Vermeersch M; Storme G; Van den Berge D; Gevaert T; Sermeus A; De Ridder M, 2013. Hepatocytes determine the hypoxic microenvironment and radiosensitivity of colorectal cancer cells through production of nitric oxide that targets mitochondrial respiration.  Int J Radiat Oncol Biol Phys 85(3):820-7

Gevaert T; Levivier M; Lacornerie T; Verellen D; Engels B; Reynaert N; Tournel K; Duchateau M; Reynders T; Depuydt T; Collen C; Lartigau E; De Ridder M, 2013. Dosimetric comparison of different treatment modalities for stereotactic radiosurgery of arteriovenous malformations and acoustic neuromas.  Radiother Oncol 106(2):192-7

Gevaert T; Boussaer M; Engels B; Litré CF; Prieur A; Wdowczyk D; Verellen D; Storme G; D'Haens J; Colin P; De Ridder M, 2013. Evaluation of the clinical usefulness for using verification images during frameless radiosurgery.  Radiother Oncol 108(1):114-7

Norkus D; Karklelyte A; Engels B; Versmessen H; Griskevicius R; De Ridder M; Storme G; Aleknavicius E; Janulionis E; Valuckas KP, 2013. A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients.  Radiat Oncol 8:206

Poels K; Depuydt T; Verellen D; Engels B; Collen C; Heinrich S; Duchateau M; Reynders T; Leysen K; Boussaer M; Steenbeke F; Tournel K; Gevaert T; Storme G; De Ridder M, 2013. A complementary dual-modality verification for tumor tracking on a gimbaled linac system.  Radiother Oncol 109(3):469-74

Grandjean M; Sermeus A; Branders S; Defresne F; Dieu M; Dupont P; Raes M; De Ridder M; Feron O, 2013. Hypoxia integration in the serological proteome analysis unmasks tumor antigens and fosters the identification of anti-phospho-eEF2 antibodies as potential cancer biomarkers.  PLoS One 8(10):e76508

Gevaert T; Verellen D; Engels B; Depuydt T; Heuninckx K; Tournel K; Duchateau M; Reynders T; De Ridder M, 2012. Clinical evaluation of a robotic 6-degree of freedom treatment couch for frameless radiosurgery.  Int J Radiat Oncol Biol Phys 83(1):467-74

Engels B; Tournel K; Everaert H; Hoorens A; Sermeus A; Christian N; Storme G; Verellen D; De Ridder M, 2012. Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer.  Int J Radiat Oncol Biol Phys 83(1):142-8

Engels B; Gevaert T; Everaert H; De Coninck P; Sermeus A; Christian N; Storme G; Verellen D; De Ridder M, 2012. Phase II study of helical tomotherapy in the multidisciplinary treatment of oligometastatic colorectal cancer.  Radiat Oncol 7:34

Depuydt T; Penne R; Verellen D; Hrbacek J; Lang S; Leysen K; Vandevondel I; Poels K; Reynders T; Gevaert T; Duchateau M; Tournel K; Boussaer M; Cosentino D; Garibaldi C; Solberg T; De Ridder M, 2012. Computer-aided analysis of star shot films for high-accuracy radiation therapy treatment units.  Phys Med Biol 57(10):2997-3011

Adriaenssens N; De Ridder M; Lievens P; Van Parijs H; Vanhoeij M; Miedema G; Voordeckers M; Versmessen H; Storme G; Lamote J; Pauwels S; Vinh-Hung V, 2012. Scapula alata in early breast cancer patients enrolled in a randomized clinical trial of post-surgery short-course image-guided radiotherapy.  World J Surg Oncol 10:86

Engels B; Gevaert T; Sermeus A; De Ridder M, 2012. Current status of intensified neo-adjuvant systemic therapy in locally advanced rectal cancer.  Front Oncol 2:47

Du Four S; Wilgenhof S; Duerinck J; Michotte A; Van Binst A; De Ridder M; Neyns B, 2012. Radiation necrosis of the brain in melanoma patients successfully treated with ipilimumab, three case studies.  Eur J Cancer 48(16):3045-51

Van Parijs H; Miedema G; Vinh-Hung V; Verbanck S; Adriaenssens N; Kerkhove D; Reynders T; Schuermans D; Leysen K; Hanon S; Van Camp G; Vincken W; Storme G; Verellen D; De Ridder M, 2012. Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial.  Radiat Oncol 7:80

Vinh-Hung V; Everaert H; Lamote J; Voordeckers M; van Parijs H; Vanhoeij M; Verfaillie G; Fontaine C; Vees H; Ratib O; Vlastos G; De Ridder M, 2012. Diagnostic and prognostic correlates of preoperative FDG PET for breast cancer.  Eur J Nucl Med Mol Imaging 39(10):1618-27

Voordeckers M; Farrag A; Everaert H; Tournel K; Storme G; Verellen D; De Ridder M, 2012. Parotid gland sparing with helical tomotherapy in head-and-neck cancer.  Int J Radiat Oncol Biol Phys 84(2):443-8

Gevaert T; Engels B; Garibaldi C; Verellen D; Deconinck P; Duchateau M; Reynders T; Tournel K; De Ridder M, 2012. Implementation of HybridArc treatment technique in preoperative radiotherapy of rectal cancer: dose patterns in target lesions and organs at risk as compared to helical Tomotherapy and RapidArc.  Radiat Oncol 7:120

Adriaenssens N; Vinh-Hung V; Miedema G; Versmessen H; Lamote J; Vanhoeij M; Lievens P; van Parijs H; Storme G; Voordeckers M; De Ridder M, 2012. Early contralateral shoulder-arm morbidity in breast cancer patients enrolled in a randomized trial of post-surgery radiation therapy.  Breast Cancer (Auckl) 6:79-93

Verbanck S; Hanon S; Schuermans D; Van Parijs H; Vinh-Hung V; Miedema G; Verellen D; Storme G; Vanhoeij M; Lamote J; De Ridder M; Vincken W, 2012. Small airways function in breast cancer patients before and after radiotherapy.  Breast Cancer Res Treat 135(3):857-65

Versmessen H; Vinh-Hung V; Van Parijs H; Miedema G; Voordeckers M; Adriaenssens N; Storme G; De Ridder M, 2012. Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy.  BMC Cancer 12:495

Gevaert T; Verellen D; Tournel K; Linthout N; Bral S; Engels B; Collen C; Depuydt T; Duchateau M; Reynders T; Storme G; De Ridder M, 2012. Setup accuracy of the Novalis ExacTrac 6DOF system for frameless radiosurgery.  Int J Radiat Oncol Biol Phys 82(5):1627-35

Bral S; De Ridder M; Duchateau M; Gevaert T; Engels B; Schallier D; Storme G, 2011. Daily megavoltage computed tomography in lung cancer radiotherapy: correlation between volumetric changes and local outcome.  Int J Radiat Oncol Biol Phys 80(5):1338-42

Everaert H; Hoorens A; Vanhove C; Sermeus A; Ceulemans G; Engels B; Vermeersch M; Verellen D; Urbain D; Storme G; De Ridder M, 2011. Prediction of response to neoadjuvant radiotherapy in patients with locally advanced rectal cancer by means of sequential 18FDG-PET.  Int J Radiat Oncol Biol Phys 80(1):91-6

Collen C; Ampe B; Gevaert T; Moens M; Linthout N; De Ridder M; Verellen D; D'Haens J; Storme G, 2011. Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience.  Int J Radiat Oncol Biol Phys 81(4):e503-9

Bral S; Gevaert T; Linthout N; Versmessen H; Collen C; Engels B; Verdries D; Everaert H; Christian N; De Ridder M; Storme G, 2011. Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a Phase II trial.  Int J Radiat Oncol Biol Phys 80(5):1343-9

Sullivan R; Peppercorn J; Sikora K; Zalcberg J; Meropol NJ; Amir E; Khayat D; Boyle P; Autier P; Tannock IF; Fojo T; Siderov J; Williamson S; Camporesi S; McVie JG; Purushotham AD; Naredi P; Eggermont A; Brennan MF; Steinberg ML; De Ridder M; McCloskey SA; Verellen D; Roberts T; Storme G; Hicks RJ; Ell PJ; Hirsch BR; Carbone DP; Schulman KA; Catchpole P; Taylor D; Geissler J; Brinker NG; Meltzer D; Kerr D; Aapro M, 2011. Delivering affordable cancer care in high-income countries.  Lancet Oncol 12(10):933-80

Depuydt T; Verellen D; Haas O; Gevaert T; Linthout N; Duchateau M; Tournel K; Reynders T; Leysen K; Hoogeman M; Storme G; De Ridder M, 2011. Geometric accuracy of a novel gimbals based radiation therapy tumor tracking system.  Radiother Oncol 98(3):365-72

Collen C; Engels B; Duchateau M; Tournel K; De Ridder M; Bral S; Verellen D; Storme G, 2010. Volumetric imaging by megavoltage computed tomography for assessment of internal organ motion during radiotherapy for cervical cancer.  Int J Radiat Oncol Biol Phys 77(5):1590-5

Jiang H; De Ridder M; Verovski VN; Sonveaux P; Jordan BF; Law K; Monsaert C; Van den Berge DL; Verellen D; Feron O; Gallez B; Storme GA, 2010. Activated macrophages as a novel determinant of tumor cell radioresponse: the role of nitric oxide-mediated inhibition of cellular respiration and oxygen sparing.  Int J Radiat Oncol Biol Phys 76(5):1520-7

Verellen D; Van Vaerenbergh S; Tournel K; Heuninckx K; Joris L; Duchateau M; Linthout N; Gevaert T; Reynders T; Van de Vondel I; Coppens L; Depuydt T; De Ridder M; Storme G, 2010. An in-house developed resettable MOSFET dosimeter for radiotherapy.  Phys Med Biol 55(4):N97-109

Bral S; Duchateau M; Versmessen H; Engels B; Tournel K; Vinh-Hung V; De Ridder M; Schallier D; Storme G, 2010. Toxicity and outcome results of a class solution with moderately hypofractionated radiotherapy in inoperable Stage III non-small cell lung cancer using helical tomotherapy.  Int J Radiat Oncol Biol Phys 77(5):1352-9

Bral S; Duchateau M; Versmessen H; Verdries D; Engels B; De Ridder M; Tournel K; Collen C; Everaert H; Schallier D; De Greve J; Storme G, 2010. Toxicity report of a phase 1/2 dose-escalation study in patients with inoperable, locally advanced nonsmall cell lung cancer with helical tomotherapy and concurrent chemotherapy.  Cancer 116(1):241-50

Bral S; Duchateau M; De Ridder M; Everaert H; Tournel K; Schallier D; Verellen D; Storme G, 2009. Volumetric response analysis during chemoradiation as predictive tool for optimizing treatment strategy in locally advanced unresectable NSCLC.  Radiother Oncol 91(3):438-42

Engels B; De Ridder M; Tournel K; Sermeus A; De Coninck P; Verellen D; Storme GA, 2009. Preoperative helical tomotherapy and megavoltage computed tomography for rectal cancer: impact on the irradiated volume of small bowel.  Int J Radiat Oncol Biol Phys 74(5):1476-80

Chaskis C; Neyns B; Michotte A; De Ridder M; Everaert H, 2009. Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations.  Surg Neurol 72(4):423-8

De Ridder M; Van Esch G; Engels B; Verovski V; Storme G, 2008. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.  Bull Cancer 95(3):282-91

De Ridder M; Tournel K; Van Nieuwenhove Y; Engels B; Hoorens A; Everaert H; Op de Beeck B; Vinh-Hung V; De Grève J; Delvaux G; Verellen D; Storme GA, 2008. Phase II study of preoperative helical tomotherapy for rectal cancer.  Int J Radiat Oncol Biol Phys 70(3):728-34

Verellen D; De Ridder M; Storme G, 2008. A (short) history of image-guided radiotherapy.  Radiother Oncol 86(1):4-13

De Ridder M; Jiang H; Van Esch G; Law K; Monsaert C; Van den Berge DL; Verellen D; Verovski VN; Storme GA, 2008. IFN-gamma+ CD8+ T lymphocytes: possible link between immune and radiation responses in tumor-relevant hypoxia.  Int J Radiat Oncol Biol Phys 71(3):647-51

De Ridder M; Verellen D; Verovski V; Storme G, 2008. Hypoxic tumor cell radiosensitization through nitric oxide.  Nitric Oxide 19(2):164-9

Tournel K; De Ridder M; Engels B; Bijdekerke P; Fierens Y; Duchateau M; Linthout N; Reynders T; Verellen D; Storme G, 2008. Assessment of intrafractional movement and internal motion in radiotherapy of rectal cancer using megavoltage computed tomography.  Int J Radiat Oncol Biol Phys 71(3):934-9

Neyns B; Aerts M; Van Nieuwenhove Y; Fontaine C; De Coster L; Schallier D; Vanderauwera J; De Munck F; Vandenbroucke F; Everaert H; Meert V; De Mey J; De Ridder M; Delvaux G; De Grève J, 2008. Cetuximab with hepatic arterial infusion of chemotherapy for the treatment of colorectal cancer liver metastases.  Anticancer Res 28(4C):2459-67

Verellen D; De Ridder M; Linthout N; Tournel K; Soete G; Storme G, 2007. Innovations in image-guided radiotherapy.  Nat Rev Cancer 7(12):949-60

Vinh-Hung V; Bourgain C; Vlastos G; Cserni G; De Ridder M; Storme G; Vlastos AT, 2007. Prognostic value of histopathology and trends in cervical cancer: a SEER population study.  BMC Cancer 7:164

De Ridder M; Verovski VN; Chiavaroli C; Van den Berge DL; Monsaert C; Law K; Storme GA, 2006. The radiosensitizing effect of immunoadjuvant OM-174 requires cooperation between immune and tumor cells through interferon-gamma and inducible nitric oxide synthase.  Int J Radiat Oncol Biol Phys 66(5):1473-80

Neyns B; Sadones J; Chaskis C; De Ridder M; Keyaerts M; Veld PI; Michotte A, 2005. The role of chemotherapy in the treatment of low-grade glioma. A review of the literature.  Acta Neurol Belg 105(3):137-43

Asosingh K; De Raeve H; de Ridder M; Storme GA; Willems A; Van Riet I; Van Camp B; Vanderkerken K, 2005. Role of the hypoxic bone marrow microenvironment in 5T2MM murine myeloma tumor progression.  Haematologica 90(6):810-7

De Ridder M; Verovski VN; Darville MI; Van Den Berge DL; Monsaert C; Eizirik DL; Storme GA, 2004. Macrophages enhance the radiosensitizing activity of lipid A: a novel role for immune cells in tumor cell radioresponse.  Int J Radiat Oncol Biol Phys 60(2):598-606

De Ridder M; Sermeus AB; Urbain D; Storme GA, 2003. Metastases to the thyroid gland-a report of six cases.  Eur J Intern Med 14(6):377-379

de Ridder M; Verovski VN; Van den Berge DL; Sermeus AB; Monsaert C; Wauters N; Storme GA, 2003. Lipid a radiosensitizes hypoxic EMT-6 tumor cells: role of the NF-kappaB signaling pathway.  Int J Radiat Oncol Biol Phys 57(3):779-86

Publication list retrieved from NCBI using ImpactPubs

.